Ad is loading...

DMAC DiaMedica Therapeutics Forecast, Technical & Fundamental Analysis

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Get AI intraday signals

DMAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For DMAC
(Try 14 days for Free)

View a ticker or compare two or three

Compare

DMAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For DMAC
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

DMAC is expected to report earnings to rise 15.00% to -17 cents per share on March 25

DiaMedica Therapeutics DMAC Stock Earnings Reports

Q4'24

Est.

$-0.17

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.02

The last earnings report on November 13 showed earnings per share of -15 cents, beating the estimate of -15 cents. With 1.08M shares outstanding, the current market capitalization sits at 171.90M.

A.I. Advisor

published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

301 Carlson Parkway

Phone

+1 763 496-5454

Employees

Web

https://www.diamedica.com

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
MLPIX	119.74	1.94	+1.65%
ProFunds Mid Cap Value Inv
AVFIX	28.49	0.45	+1.60%
American Beacon Small Cp Val R5
FSCVX	27.96	0.43	+1.56%
Nuveen Small Cap Value C
MSVSX	10.14	N/A	N/A
MassMutual Small Company Val R5
AGOZX	21.35	N/A	N/A
Alger Small Cap Focus Z

DMAC and Stocks

Correlation & Price change

A.I.dvisor tells us that DMAC and AVXL have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DMAC and AVXL's prices will move in lockstep.

Ticker / NAME	Correlation To DMAC	1D Price Change %
DMAC	100%	-0.50%
AVXL - DMAC	26% Poorly correlated	+2.85%
PCVX - DMAC	26% Poorly correlated	-1.29%
STTK - DMAC	24% Poorly correlated	-2.63%
ARVN - DMAC	24% Poorly correlated	+4.85%
XERS - DMAC	24% Poorly correlated	+1.66%
More